AlphAIalphai — Financial news for AI agents
SEC EDGARSEP 11 min read$TRUP

GALLAGHER JOHN R sold $107K of TRUP

GALLAGHER JOHN R (Chief Operating Officer) sold 3,604 shares of TRUPANION, INC. (TRUP) at $29.70 ($0.11M total) on 2026-08-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · GALLAGHER JOHN R
Published Sep 1, 2026, 11:37 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 1, 2026, 11:40 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$TRUP
Neutral
high confidence
Mentioned
$TRUP
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRUPNeutralLow
01

Why it matters

The transaction is routine and low‑value, offering limited actionable insight for traders.

02

Market read

A small insider sell with no immediate market impact; primarily of interest to compliance monitors.

03

What to watch

Potential upcoming clinical trial results or financing events could change the relevance of this sale.

Relevance 3/10Novelty 3/10Timing: filed Sep 1 2026 (after‑hours)

Background

Form 4 filings disclose insider transactions; they are primary sources for regulatory disclosures.

Company-level read

Ticker impact

$TRUPNeutralHigh confidence
Context

Chief Operating Officer John Gallagher sold 3,604 shares for $107,038 via a 10b5‑1 plan, reducing his stake to 33,742 shares.

Expected impact

No significant price impact expected.

Evidence & confidence

The sale is under $0.2 M and follows a pre‑arranged plan, indicating routine portfolio rebalancing rather than a red flag.

Market effects

Sector

No broader sector impact; biotech insider sales are common and typically isolated.

Regional

None; the filing is company‑specific.

Global

Minimal; only relevant to TRUP shareholders.

Counterpoint

What could challenge this read

If the insider had insider knowledge, the sale could hint at upcoming negative news, but the 10b5‑1 plan weakens this argument.

Key entities

  • Company
    Trupanion, Inc.

    US‑listed pet insurance provider (NASDAQ:TRUP).

  • Executive
    John Gallagher

    Chief Operating Officer of Trupanion.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

TRUP insider trading history →

Related articles

AUG 26
$TRUPMed

Why Trupanion (TRUP) Shares Are Sliding Today

Trupanion (TRUP) shares fell 5.8% after Piper Sandler downgraded the stock to Neutral, citing challenges in the pet insurance market and rising claim costs. The firm lowered its price target to $32 from $45. The stock has seen significant volatility, down 19.6% year-to-date and 35.6% from its 52-week high.

financialcontent.com2 min
AUG 26
$TRUPHigh

Why is Trupanion stock sliding today?

Trupanion stock fell 6.4% after Piper Sandler downgraded it to Neutral and cut its price target to $32 from $45, citing revenue and margin pressures. Zacks Research also downgraded the stock, amplifying the selloff. The company's shares have retreated from their 52-week high of $46.98, trading near the 52-week low of $21.16.

investing.com2 min
AUG 15
$TRUPMed

Trupanion (TRUP) Is Up 13.4% After New Vet Partnerships and Q2 Results - Has The Bull Case Changed?

Trupanion reported Q2 2026 results with net income of $6.83 million and updated revenue guidance, and it announced new partnerships and integrations with Digitail and Home To Home. The article links VetDirect Pay and Exam Day coverage to pet-care workflows and discusses margin and subscription growth targets, including projected $2.0 billion revenue and $36.5 million earnings by 2029.

simplywall.st7 min
AUG 6
$METMed

Financial results round-up: MetLife, Prudential, Corebridge, Palomar, Heritage, TWFG, Root and more

A financial results roundup covers multiple insurers and MGAs. MetLife reported Q2 net income of $705m and adjusted EPS $2.43. Prudential posted Q2 net income of $985m and record individual life sales. Corebridge reported a $16m net loss and merger approval. Palomar, Heritage, TWFG, Root, Trupanion and Clover Health also reported Q2 figures and guidance updates.

insurancebusinessmag.com9 min
AUG 5
$TRUPMed

TRUPANION, INC. (TRUP): Results of Operations and Financial Condition

TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Trupanion Reports Second Quarter 2026 Results Authorizes Share Repurchase Program SEATTLE, WA. August 5, 2026 -- Trupanion , Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended

SEC EDGAR 8-K6 min